Autopsy report · NCT04283526

Study of Select Combinations in Adults With Myelofibrosis

“This study was cancelled before enrolling any patients for business related reasons.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Novartis Pharmaceuticals

Sponsor type

Industry

Conditions

Primary Myelofibrosis; Myelofibrosis; PMF; Post-Essential Thrombocythemia Myelofibrosis; Post-Polycythemia Vera Myelofibrosis

Interventions

MBG453; NIS793; Spartalizumab; Decitabine

Participants

0

Trials that died the same way

• Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
  “This study has been cancelled due to business reasons” (80% match in meaning)
• Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer
  “This study was withdrawn due to a strategic business decision; no patients were enrolled.” (76% match in meaning)
• Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke
  “study was stopped for business/administrative reasons and not for patient safety concerns” (76% match in meaning)
• Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.
  “the clinical study was canceled by the sponsor due to logistics and programming” (75% match in meaning)
• Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine
  “Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.